Prostate-specific Membrane Antigen PET in Prostate Cancer

被引：52

作者：

Lawhn-Heath, Courtney ^{[1
]}

Salavati, Ali ^{[3
]}

Behr, Spencer C. ^{[1
,2
]}

Rowe, Steven P. ^{[3
]}

Calais, Jeremie ^{[4
]}

Fendler, Wolfgang P. ^{[5
,6
]}

Eiber, Mattias ^{[7
]}

Emmett, Louise ^{[8
]}

Hofman, Michael S. ^{[9
,10
]}

Hope, Thomas A. ^{[1
,2
]}

机构：

[1] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, 505 Parnassus Ave,M391, San Francisco, CA 94143 USA

[2] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, 505 Parnassus Ave,M391, San Francisco, CA 94143 USA

[3] Johns Hopkins Univ, Dept Radiol & Radiol Sci, Baltimore, MD USA

[4] Univ Calif Los Angeles, David Geffen Sch Med, Ahmanson Translat Theranost Div, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA

[5] Univ Duisburg Essen, Dept Nudear Med, Essen, Germany

[6] Univ Hosp Essen, German Canc Consortium DKTK, Essen, Germany

[7] Tech Univ Munich, Dept Nucl Med, Munich, Germany

[8] St Vincents Hosp, Dept Theranost & Nucl Med, Sydney, NSW, Australia

[9] Peter MacCallum Canc Ctr, Prostate Theranost & Imaging Ctr Excellence ProsT, Melbourne, Vic, Australia

[10] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia

来源：

RADIOLOGY | 2021年 / 299卷 / 02期

关键词：

I-AND-T; BIOCHEMICAL RECURRENCE; RADIATION-DOSIMETRY; RADICAL PROSTATECTOMY; GA-68-PSMA-11; PET/CT; BIODISTRIBUTION; RADIOTHERAPY; THERAPY; MEN; RECOMMENDATIONS;

D O I：

10.1148/radiol.2021202771

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Prostate-specific membrane antigen (PSMA)-targeted radiopharmaceuticals are playing a large role at the time of initial staging and biochemical recurrence for localizing prostate cancer, as well as in other emerging clinical settings. PSMA PET has demonstrated increased detection rate compared with conventional imaging and has been shown to change management plans in a substantial percentage of cases. The aims of this narrative review are to highlight the development and clinical impact of PSMA PET-radiopharmaceuticals, to compare PSMA to other agents such as fluorine 18 fluciclovine and carbon 11 choline, and to highlight some of the individual PSMA PET agents that have contributed to the advancement of prostate cancer imaging. (C) RSNA, 2021

引用

页码：248 / 260

页数：13

共 50 条

[21] Prostate-Specific Membrane Antigen-Targeted Radiohalogenated PET and Therapeutic Agents for Prostate Cancer
Rowe, Steven P.
Drzezga, Alexander
Neumaier, Bernd
Dietlein, Markus
Gorin, Michael A.
Zalutsky, Michael R.
Pomper, Martin G.
JOURNAL OF NUCLEAR MEDICINE, 2016, 57 : 90S - 96S
[22] PROSTATE-SPECIFIC MEMBRANE ANTIGEN PET FOR INITIAL STAGING OF PROSTATE CANCER: AN ACADEMIC CENTER EXPERIENCE
Umar, Ghaffar
Jeffrey, Karnes R.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S19 - S19
[23] Imaging Prostate Cancer With Prostate-Specific Membrane Antigen PET/CT and PET/MRI: Current and Future Applications
Hope, Thomas A.
Afshar-Oromieh, Ali
Eiber, Matthias
Emmett, Louise
Fendler, Wolfgang P.
Lawhn-Heath, Courtney
Rowe, Steven P.
AMERICAN JOURNAL OF ROENTGENOLOGY, 2018, 211 (02) : 286 - 294
[24] Prostate-specific antigen and prostate cancer
Rosalki, SB
Rutherford, FJ
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2000, 54 (09) : 611 - 613
[25] Prostate-specific membrane antigen
Maraj, BH
Whelan, P
Markham, AF
BRITISH JOURNAL OF UROLOGY, 1998, 81 (04): : 523 - 528
[26] Prostate-specific membrane antigen
Fair, WR
Israeli, RS
Heston, WDW
PROSTATE, 1997, 32 (02): : 140 - 148
[27] COMPARISON OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN, AND PROSTATE-SPECIFIC ANTIGEN LEVELS IN PROSTATIC-CANCER PATIENTS
MURPHY, G
RAGDE, H
KENNY, G
BARREN, R
ERICKSON, S
TJOA, B
BOYNTON, A
HOLMES, E
GILBAUGH, J
DOUGLAS, T
ANTICANCER RESEARCH, 1995, 15 (04) : 1473 - 1479
[28] The Probability of Prostate Cancer Metastases within different Prostate-Specific Antigen ranges using Primary Staging Prostate-Specific Membrane Antigen PET/CT in Patients with Newly Diagnosed Prostate Cancer
Luining, W.
Hagens, M. J.
Meijer, D.
Srbljin, S.
Koppes, J. C. C.
Knol, R. J. J.
van Leeuwen, P. J.
Vis, A. N.
Oprea-Lager, D. E.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S174 - S175
[29] Prostate-specific membrane antigen expression predicts prostate cancer recurrence
不详
ONCOLOGY-NEW YORK, 2006, 20 (07): : 790 - 790
[30] Opportunities for prostate-specific membrane antigen hybrid imaging in prostate cancer
Strauss, Anna-Sophie
Bolenz, Christian
Beer, Ambros J.
Zengerling, Friedemann
Beer, Meinrad
Miksch, Jonathan
UROLOGIE, 2023, 62 (11): : 1153 - 1159

← 1 2 3 4 5 →